In SCID mice, an immune-deficient mouse line lacking functional T and B lymphocytes, HVJ-E/OX40 antibody did not affect tumor growth at the non-target lesion (p > 0.9201, Figure 2E). Here, TNFRSF4 is linked to neoplasm.